2-Propanol: Clinical Trials

41 trials of 2-Propanol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 3 active not recruiting, 3 terminated, 3 unknown. 11 Phase 2, 10 Not applicable, 9 Phase 3, 6 Phase 4, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Active not recruiting 3, Completed 3, Not yet recruiting 2, Recruiting 1, Suspended 1, Terminated 1
Not applicable10Completed 7, Unknown 3
Phase 39Completed 8, Terminated 1
Phase 46Completed 4, Recruiting 1, Terminated 1
Phase 14Completed 2, Suspended 1, Withdrawn 1
Early Phase 11Completed 1

Follow 2-Propanol: new trials by email Literature Review of 2-Propanol trials Research Report on 2-Propanol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
Isopropyl Alcohol, Placebo, Questionnaire Administration - Malignant Neoplasm
Phase 2Not yet recruitingM.D. Anderson Cancer Center1122026-11-052026-05-27
Propranolol Treatment for Postoperative Chylothorax
Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease
Phase 1 / Phase 2SuspendedJune Wu502025-09-092026-05-15
Cleaning the Biopsy Needle in TRUS Bx
Isopropyl Alcohol, Povidine-iodine, formaldehit - Prostatic Cancer
Phase 2Not yet recruitingHitit University2002025-03-012025-02-20
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 2Active not recruitingChildren's Oncology Group12023-08-142026-01-09
Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Cobimetinib, Enasidenib Mesylate - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1CompletedCity of Hope Medical Center32023-04-282026-05-05
Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation
Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate - Recurrent Acute Myeloid Leukemia
Phase 1WithdrawnCity of Hope Medical Center2022-06-252022-06-09
Skin Preparation for Elective Foot and Ankle Surgery
Hibiclens, Isopropyl Alcohol 70% Topical Application Solution - Microbial Colonization, Foot and Ankle Disorders
Phase 4RecruitingUniversity of Missouri-Columbia1002022-02-152026-04-27
Inhaled Isopropyl Alcohol Versus Placebo to Manage Nausea at Electronic Dance Music Festivals
Isopropyl alcohol, Placebo - Nausea
Not applicableCompletedAnthony Seto552021-07-122025-04-09
Skin Microbiome and Polymorphic Light Eruption
Octeniderm (octenidine dihydrochloride, 1-propanol, 2- propanol) - Polymorphic Light Eruption
Not applicableUnknownMedical University of Graz302021-05-072021-08-02
Preoperative Skin Preparation Study to Evaluate the Antimicrobial Capabilities of Four Test Substances
Isopropyl alcohol & Chlorhexidine Gluconate Antiseptic, Prevantics 3.15 % / 70 % Swabstick - Surgical Site Infection
Phase 3CompletedProfessional Disposables International, Inc.3292020-02-112021-10-22
Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
Enasidenib Mesylate - Acute Myeloid Leukemia
Phase 2Active not recruitingCity of Hope Medical Center352019-12-232026-11-10
CPX-351 Plus Enasidenib for Relapsed AML
Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine - Recurrent Acute Myeloid Leukemia
Phase 2Active not recruitingJonsson Comprehensive Cancer Center22019-04-122023-09-28
Comparison of Two Preoperative Antiseptic Solutions Alcohol Based in Abdominal Elective Surgeries
Iodine Povacrylex 7 MG/ML / Isopropyl Alcohol 0.74 ML/ML, Chlorhexidine Gluconate 20 MG/ML / Isopropyl Alcohol 0.7 ML/ML - Surgical Site Infection
Phase 4TerminatedUniversidad de El Salvador182019-04-052023-05-10
Usage of Multiple Drugs in Treatment of Postoperative Vomiting After Laparoscopic Appendectomy
Ondansetron, isopropyl alcohol 70% inhalation, laparoscopic appendectomy - to Treat the Vomiting Frequently Occur Post-laparoscopic by Different Anti Emetic Drugs
CompletedKing Abdul Aziz Specialist Hospital2402019-03-102020-05-28
AvenovaTM as a Sterile Skin Preparation Agent
Avenova, Povidone-iodine 5% solution, 4% chlorhexidine - Cleaning Product Causing Toxic Effect
Early Phase 1CompletedUniversity of Miami212018-12-012020-02-05
A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs
Chlorhexidine gluconate, Isopropyl Alcohol 70% Topical Application Solution, Skin Prep Before Injecting Recreational/Street Drugs - Opioid Use Disorder, Injection Drug Use
Phase 4CompletedGabriel John Culbert562018-10-012025-08-03
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Azacitidine, Enasidenib Mesylate - Acute Bilineal Leukemia, Acute Biphenotypic Leukemia
Phase 2RecruitingM.D. Anderson Cancer Center502018-09-182026-09-14
Study of A-101 Topical Solution for the Treatment of Common Warts
A-101, vehicle - Common Wart
Phase 3CompletedAclaris Therapeutics, Inc.5032018-09-172020-10-05
A Study of A-101 Topical Solution for the Treatment of Common Warts
Active, Vehicle - Common Wart
Phase 3CompletedAclaris Therapeutics, Inc.5022018-09-132020-10-27
Does the Addition of Hydrogen Peroxide to Chlorhexidine Skin Prep to Treat P. Acnes in the Shoulder
a. Standard iodine scrub, 3% hydrogen peroxide prep, follow by ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol, Iodine scrub and ChloraPrep alone - Propionibacterium Infection
Not applicableUnknownRothman Institute Orthopaedics1002018-04-162018-09-04

Showing 20 of 41. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (6)  ·  Surgical Wound Infection (5)  ·  Communicable Diseases (4)  ·  Bacteremia (2)  ·  Nausea (2)  ·  Sepsis (2)  ·  Warts (2)  ·  Bacterial Infections (1)  ·  Bites and Stings (1)  ·  Catheter-Related Infections (1)  ·  Chylothorax (1)  ·  Erythema (1)  ·  Heart Defects, Congenital (1)  ·  Infections (1)  ·  Leukemia, Biphenotypic, Acute (1)

Sponsors

Solventum US LLC (4)  ·  City of Hope Medical Center (3)  ·  Universidad de Guanajuato (3)  ·  Aclaris Therapeutics, Inc. (2)  ·  C. R. Bard (2)  ·  M.D. Anderson Cancer Center (2)  ·  Zurex Pharma, Inc. (2)  ·  3M (1)  ·  Anthony Seto (1)  ·  Children's Oncology Group (1)  ·  Gabriel John Culbert (1)  ·  Hitit University (1)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  June Wu (1)

Countries

United States (25)  ·  Canada (3)  ·  Mexico (3)  ·  Romania (2)  ·  Austria (1)  ·  El Salvador (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Saudi Arabia (1)  ·  Switzerland (1)

Top investigators

Rozalia Olsavszky, MD (3)  ·  Muhammad H Bashir, MD (2)  ·  Alejandro E Macias, M. D. (1)  ·  Alejandro E. Macias, M. D. (1)  ·  Amandeep Salhotra (1)  ·  Anthony V Seto, MD (1)  ·  Brian Ball (1)  ·  Caspian Oliai, MD (1)  ·  Chris Beausoleil (1)  ·  Christopher Nunez, PhD (1)  ·  Courtney DiNardo (1)  ·  George W Brindley, MD (1)  ·  Guido Marcucci (1)  ·  Jamie Miller, ADN (1)  ·  John Yuen, PhD (1)

Results publications

PMID 19686276, PMID 33394722, PMID 35078972, PMID 35184146, PMID 42369177, PMID 42493725

NIH funding

P30CA033572 (2), U10CA180886 (1)